Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Lisata Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q3 2025
- Shares held
- 715.1K
- −24.1K (−3.3%) vs. Q3 2025
- Total value
- $1.36M
- −$578.5K (−29.9%) vs. Q3 2025
- New holders
- 6
- 7 more added
- Sold out
- 2
- 6 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LSTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $3.70M |
| Q1 2026 | 34 | $7.06M |
| Q4 2025 | 25 | $1.36M |
| Q3 2025 | 21 | $1.93M |
| Q2 2025 | 20 | $2.26M |
| Q1 2025 | 22 | $1.84M |
| Q4 2024 | 21 | $2.33M |
| Q3 2024 | 20 | $2.30M |
| Q2 2024 | 22 | $2.61M |
| Q1 2024 | 21 | $2.30M |
| Q4 2023 | 22 | $2.03M |
| Q3 2023 | 21 | $1.46M |
| Q2 2023 | 22 | $2.51M |
| Q1 2023 | 21 | $2.08M |
| Q4 2022 | 24 | $1.83M |
| Q3 2022 | 22 | $2.17M |
| Q2 2022 | 36 | $5.00M |
| Q1 2022 | 34 | $6.13M |
| Q4 2021 | 36 | $7.33M |
| Q3 2021 | 34 | $9.41M |
| Q2 2021 | 29 | $10.1M |
| Q1 2021 | 33 | $12.9M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Lisata Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 270,909 | $503.9K | 0.00% | +395+0.1% | Added |
| Renaissance Technologies LLC | 123,715 | $230.1K | 0.00% | +7,093+6.1% | Added |
| BML Capital Management, LLC | 73,348 | $136.4K | 0.12% | −36,493−33.2% | Reduced |
| Geode Capital Management, LLC | 64,428 | $119.9K | 0.00% | +1,168+1.8% | Added |
| BlackRock, Inc. | 54,857 | $102.0K | 0.00% | −33−0.1% | Reduced |
| Ground Swell Capital, LLC | 38,987 | $72.5K | 0.15% | +15,213+64.0% | Added |
| Cerity Partners LLC | 12,183 | $49.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 14,348 | $26.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 14,253 | $26.5K | 0.00% | −6,694−32.0% | Reduced |
| Bank of America Corp | 10,418 | $19.4K | 0.00% | +10.0% | Added |
| Northern Trust Corp | 10,268 | $19.1K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 10,042 | $18.7K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,913 | $11.0K | 0.00% | +10.0% | Added |
| International Assets Investment Management, LLC | 5,000 | $9.30K | 0.00% | +5,000 | New |
| Tower Research Capital LLC (TRC) | 2,552 | $4.75K | 0.00% | +881+52.7% | Added |
| Founders Capital Management | 1,667 | $3.10K | 0.00% | −333−16.7% | Reduced |
| Connective Capital Management, LLC | 1,016 | $1.89K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 871 | $1.62K | 0.00% | +871 | New |
| GWM Advisors LLC | 107 | $199 | 0.00% | +107 | New |
| Advisor Group Holdings, Inc. | 100 | $186 | 0.00% | +100 | New |
| Morgan Stanley | 75 | $140 | 0.00% | −133−63.9% | Reduced |
| Cheviot Value Management, LLC | 3 | $14 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 7 | $13 | 0.00% | −133−95.0% | Reduced |
| Citigroup Inc | 1 | $2 | 0.00% | +1 | New |
| Fortitude Family Office, LLC | 1 | $2 | 0.00% | +1 | New |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,111−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |